---
$id: https://graph.org.ai/products/commodity/51111749
$type: Product
source: UNSPSC
code: "51111749"
title: "Leurubicin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Leurubicin

**UNSPSC Code**: 51111749
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic with the molecular formula C33H40N2O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Z20MGK851, chemically known as (8s,10s)-10-((3-((s)-2-amino-4-methylvaleramido)-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione but generally known as leurubicin, which bears US NIH Compound Identifier 68897. European Medicines Agency schedules Leurubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08450MIG. The term LEURUBICIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). LEURUBICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule leurubicin under HS 29419000 and SITC 54139. As of Q4 2014, LEURUBICIN remains the US FDA Preferred Term for this commodity. Leurubicin bears US NLM identifiers UMLS ID C2825623 and NCI Concept Code C81421. SMILES: O(C1CC(O)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)C(OC)CCC2)C(=O)CO)C1OC(C(O)C(NC(=O)C(N)CC(C)C)C1)C.

